Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terhi Hermanson

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|September 30, 2015
Is Intravenous Iron Supplementation Safe to Administer to Patients on Hemodialysis with Active Infection--What Do We Know, and What More Do We Need to Know?Charles Lee Bennett, Terhi Hermanson
Blood|January 16, 2016
Big data, thromboembolism, and immunoglobulinCharles L Bennett, Terhi Hermanson
Expert Opinion on Drug Safety|August 24, 2016
Peginesatide for the treatment of anemia due to chronic kidney disease - an unfulfilled promiseTerhi Hermanson, Charles L Bennett, Iain C Macdougall
Urology|January 28, 2015
Editorial commentTerhi Hermanson, Oliver Sartor, Richard Ablin, et al.
Urology|July 6, 2015
Editorial CommentSandip Prasad, Terhi Hermanson, Charles L Bennett, et al.
BJU International|December 17, 2014
Geography: an increasingly important variable in prostate cancer clinical trialsOliver Sartor, Sumanta Kumar Pal, Terhi Hermanson, et al.
Urology|December 3, 2014
Editorial commentTerhi Hermanson, Oliver Sartor, Richard J Ablin, et al.
The Lancet. Oncology|March 11, 2015
Japanese regulatory authority's perspective on biosimilars - authors' replyCharles L Bennett, Brian Chen, Terhi Hermanson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
Toxicity and costs of toxicity associated with new cancer drugs: international implicationsTerhi Hermanson, LeAnn B Norris, John Bian, et al.
Acta Oncologica (Stockholm, Sweden)|May 16, 2023
Digital solution in the follow-up of early breast cancer a randomized studyJohanna Mattson, Maria Peltola, Paula Poikonen-Saksela, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical Journal of the American Society of Nephrology : CJASN|September 30, 2015
Is Intravenous Iron Supplementation Safe to Administer to Patients on Hemodialysis with Active Infection--What Do We Know, and What More Do We Need to Know?Charles Lee Bennett, Terhi Hermanson
Blood|January 16, 2016
Big data, thromboembolism, and immunoglobulinCharles L Bennett, Terhi Hermanson
Expert Opinion on Drug Safety|August 24, 2016
Peginesatide for the treatment of anemia due to chronic kidney disease - an unfulfilled promiseTerhi Hermanson, Charles L Bennett, Iain C Macdougall
Urology|January 28, 2015
Editorial commentTerhi Hermanson, Oliver Sartor, Richard Ablin, et al.
Urology|July 6, 2015
Editorial CommentSandip Prasad, Terhi Hermanson, Charles L Bennett, et al.
BJU International|December 17, 2014
Geography: an increasingly important variable in prostate cancer clinical trialsOliver Sartor, Sumanta Kumar Pal, Terhi Hermanson, et al.
Urology|December 3, 2014
Editorial commentTerhi Hermanson, Oliver Sartor, Richard J Ablin, et al.
The Lancet. Oncology|March 11, 2015
Japanese regulatory authority's perspective on biosimilars - authors' replyCharles L Bennett, Brian Chen, Terhi Hermanson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
Toxicity and costs of toxicity associated with new cancer drugs: international implicationsTerhi Hermanson, LeAnn B Norris, John Bian, et al.
Acta Oncologica (Stockholm, Sweden)|May 16, 2023
Digital solution in the follow-up of early breast cancer a randomized studyJohanna Mattson, Maria Peltola, Paula Poikonen-Saksela, et al.
Pageof 2